GB9922703D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9922703D0
GB9922703D0 GBGB9922703.5A GB9922703A GB9922703D0 GB 9922703 D0 GB9922703 D0 GB 9922703D0 GB 9922703 A GB9922703 A GB 9922703A GB 9922703 D0 GB9922703 D0 GB 9922703D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9922703.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9922703.5A priority Critical patent/GB9922703D0/en
Publication of GB9922703D0 publication Critical patent/GB9922703D0/en
Priority to PCT/EP2000/009366 priority patent/WO2001021207A2/en
Priority to EP00969296A priority patent/EP1221971A2/en
Priority to PL00355287A priority patent/PL355287A1/en
Priority to EP00967781A priority patent/EP1214054B1/en
Priority to CN00815945A priority patent/CN1391463A/en
Priority to CA2383105A priority patent/CA2383105C/en
Priority to AU79070/00A priority patent/AU765824B2/en
Priority to EP07119192A priority patent/EP1878424A3/en
Priority to CZ20021044A priority patent/CZ20021044A3/en
Priority to PCT/EP2000/009367 priority patent/WO2001021151A1/en
Priority to MXPA02003069A priority patent/MXPA02003069A/en
Priority to ARP000104979A priority patent/AR032597A1/en
Priority to PL00355163A priority patent/PL355163A1/en
Priority to TR2002/00776T priority patent/TR200200776T2/en
Priority to BR0014281-6A priority patent/BR0014281A/en
Priority to ES00967781T priority patent/ES2293923T3/en
Priority to HU0202846A priority patent/HUP0202846A3/en
Priority to JP2001524577A priority patent/JP4763197B2/en
Priority to TR2002/00774T priority patent/TR200200774T2/en
Priority to BR0014282-4A priority patent/BR0014282A/en
Priority to ARP000104978A priority patent/AR025750A1/en
Priority to CA002383413A priority patent/CA2383413A1/en
Priority to AT00967781T priority patent/ATE376825T1/en
Priority to AU77825/00A priority patent/AU764368B2/en
Priority to KR1020027003832A priority patent/KR20020038770A/en
Priority to IL14867300A priority patent/IL148673A0/en
Priority to KR1020027003833A priority patent/KR20020038771A/en
Priority to IL14867200A priority patent/IL148672A0/en
Priority to JP2001524631A priority patent/JP2003509473A/en
Priority to MYPI20004435 priority patent/MY126588A/en
Priority to MXPA02003067A priority patent/MXPA02003067A/en
Priority to CO00072096A priority patent/CO5200837A1/en
Priority to CN00816014A priority patent/CN1391483A/en
Priority to CZ20021043A priority patent/CZ20021043A3/en
Priority to CO00072097A priority patent/CO5280082A1/en
Priority to HU0202885A priority patent/HUP0202885A3/en
Priority to NZ517903A priority patent/NZ517903A/en
Priority to DE60036952T priority patent/DE60036952T2/en
Priority to ZA200202270A priority patent/ZA200202270B/en
Priority to NO20021433A priority patent/NO20021433L/en
Priority to NO20021431A priority patent/NO20021431L/en
Priority to HK02109233.6A priority patent/HK1049106A1/en
Priority to US11/119,994 priority patent/US20050201946A1/en
Priority to US12/388,156 priority patent/US20090155309A1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB9922703.5A 1999-09-24 1999-09-24 Vaccine Ceased GB9922703D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GBGB9922703.5A GB9922703D0 (en) 1999-09-24 1999-09-24 Vaccine
EP00969296A EP1221971A2 (en) 1999-09-24 2000-09-22 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
CA002383413A CA2383413A1 (en) 1999-09-24 2000-09-22 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
AU77825/00A AU764368B2 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
PL00355287A PL355287A1 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
AT00967781T ATE376825T1 (en) 1999-09-24 2000-09-22 INFLUENZA VIRUS VACCINE COMPOSITION FOR NASAL USE
CN00815945A CN1391463A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
CA2383105A CA2383105C (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
AU79070/00A AU765824B2 (en) 1999-09-24 2000-09-22 Vaccines
EP07119192A EP1878424A3 (en) 1999-09-24 2000-09-22 Novel vaccine
CZ20021044A CZ20021044A3 (en) 1999-09-24 2000-09-22 Use of influenza virus antigen for preparing a vaccine
PCT/EP2000/009367 WO2001021151A1 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
MXPA02003069A MXPA02003069A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine.
ARP000104979A AR032597A1 (en) 1999-09-24 2000-09-22 USE OF ANTIGENS OF THE VIRUS OF THE INACTIVATED FLU, IN THE PREPARATION OF VACCINES OF A SINGLE INTRANASAL DOSE; METHOD FOR THE PROPHYLAXIS OF DISEASES OR OF INFLUENCES IN PATIENTS; EQUIPMENT THAT INCLUDES SUCH VACCINES IN SINGLE DOSE AND METHOD FOR MANUFACTURING VACCINES FOR THE FLU FOR APLI
PL00355163A PL355163A1 (en) 1999-09-24 2000-09-22 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
TR2002/00776T TR200200776T2 (en) 1999-09-24 2000-09-22 Intranasal flu virus vaccine.
BR0014281-6A BR0014281A (en) 1999-09-24 2000-09-22 Vaccine against intranasal flu virus
ES00967781T ES2293923T3 (en) 1999-09-24 2000-09-22 INTRANASAL VACCINE AGAINST THE INFLUENZA VIRUS.
HU0202846A HUP0202846A3 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
KR1020027003832A KR20020038770A (en) 1999-09-24 2000-09-22 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
TR2002/00774T TR200200774T2 (en) 1999-09-24 2000-09-22 Vaccines.
BR0014282-4A BR0014282A (en) 1999-09-24 2000-09-22 Vaccines
ARP000104978A AR025750A1 (en) 1999-09-24 2000-09-22 VACCINES
PCT/EP2000/009366 WO2001021207A2 (en) 1999-09-24 2000-09-22 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
EP00967781A EP1214054B1 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
DE60036952T DE60036952T2 (en) 1999-09-24 2000-09-22 INFLUENZA VIRUS VACCINE COMPOSITION FOR NASAL APPLICATION
JP2001524577A JP4763197B2 (en) 1999-09-24 2000-09-22 New vaccine
IL14867300A IL148673A0 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
KR1020027003833A KR20020038771A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
IL14867200A IL148672A0 (en) 1999-09-24 2000-09-22 Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
JP2001524631A JP2003509473A (en) 1999-09-24 2000-09-22 vaccine
MYPI20004435 MY126588A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
MXPA02003067A MXPA02003067A (en) 1999-09-24 2000-09-22 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines.
CO00072096A CO5200837A1 (en) 1999-09-24 2000-09-22 VACCINES
CN00816014A CN1391483A (en) 1999-09-24 2000-09-22 Composition of octoxinol and polyvinyl chloride sorbitanate as accessory and uses in vaccins
CZ20021043A CZ20021043A3 (en) 1999-09-24 2000-09-22 Use of polyoxyethylene sorbitan ester in combination with an octoxynol for preparing an auxiliary agent
CO00072097A CO5280082A1 (en) 1999-09-24 2000-09-22 NEW VACCINE
HU0202885A HUP0202885A3 (en) 1999-09-24 2000-09-22 Vaccines
NZ517903A NZ517903A (en) 1999-09-24 2000-09-22 One dose intranasal influenza virus vaccine with split influenza viral antigens
ZA200202270A ZA200202270B (en) 1999-09-24 2002-03-20 Use of combination of polyxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines.
NO20021433A NO20021433L (en) 1999-09-24 2002-03-21 vaccinations
NO20021431A NO20021431L (en) 1999-09-24 2002-03-21 Intranasal influenza virus vaccine
HK02109233.6A HK1049106A1 (en) 1999-09-24 2002-12-19 Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
US11/119,994 US20050201946A1 (en) 1999-09-24 2005-05-02 Intranasal influenza virus vaccine
US12/388,156 US20090155309A1 (en) 1999-09-24 2009-02-18 Novel vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922703.5A GB9922703D0 (en) 1999-09-24 1999-09-24 Vaccine

Publications (1)

Publication Number Publication Date
GB9922703D0 true GB9922703D0 (en) 1999-11-24

Family

ID=10861595

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9922703.5A Ceased GB9922703D0 (en) 1999-09-24 1999-09-24 Vaccine

Country Status (2)

Country Link
GB (1) GB9922703D0 (en)
ZA (1) ZA200202270B (en)

Also Published As

Publication number Publication date
ZA200202270B (en) 2003-02-12

Similar Documents

Publication Publication Date Title
IL145043A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
HUP0202885A3 (en) Vaccines
HK1105581A1 (en) Vaccine composition
EP1083926A4 (en) Vaccine
GB9910812D0 (en) Vaccine composition
GB9915204D0 (en) Vaccine
GB9901254D0 (en) Vaccines
GB0027072D0 (en) Vaccine
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
MXPA01010701A (en) Vaccine.
GB9930591D0 (en) Component for vaccine
GB9909072D0 (en) Vaccine
GB9930585D0 (en) Component for vaccine
GB9916677D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9918647D0 (en) Vaccine
GB9922703D0 (en) Vaccine
GB9922700D0 (en) Vaccine
GB9917144D0 (en) Vaccine
GB9919260D0 (en) Vaccine
GB9927336D0 (en) Vaccine
GB9904408D0 (en) Vaccine
GB9905511D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)